Health
Novel vectors reduce the risks associated with ocular gene therapies – News-Medical.net
Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development.
Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development. Novel gene vectors now achieve widespread gene delivery and reduce the risks associated with these approaches.
The incidence of genetic mutations that result in rapid deterioration of the ability to see is larger than is generally supposed. For example, on the order of five million people around the world suffer from congenital retinal dystrophies, which often lead…
-
Noosa News24 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News12 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
General14 hours agoThe right-wing stupidity repeating Liberal Party history
-
General12 hours ago‘Economic bullying’: China hits out at US protectionism